Clinical trial
The Effect of a Contingency Management Intervention on Substance Use
NCT00252512 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00252512 |
|---|---|
| Title | The Effect of a Contingency Management Intervention on Substance Use |
| Official title | Effectiveness of Contingency Management in VA Addictions Treatment |
| Acronym | REAP |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Status | Completed |
| Study type | Interventional |
| Conditions | Substance Use Disorders |
| Intervention type | Behavioral, Other |
| Interventions | Contingency Management, Placebo |
| Enrollment | 332 |
| Start date | May 1, 2007 |
| Primary completion | Jan 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Nov 11, 2005 |
| Last update posted | Aug 16, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: